Comparison of the effects of nebivolol and bisoprolol on systemic vascular resistance in patients with essential hypertension: β-blockade and haemodynamics in hypertension

Clinical Drug Investigation

Volumn 22, Issue 6, 2002, Pages 355-359

  Brett, S E ^a   Forte, P ^b   Chowienczyk, P J ^a   Benjamin, N ^b   Ritter, J M ^a  

^a Guy'S king'S St Thomas' Medical School   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; NEBIVOLOL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASODILATATION;

EID: 0036286445     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222060-00002     Document Type: Article

References (20)

1. Nebivolol induces endothelium-dependent relaxation of canine coronary arteries
2. Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/NO dependent mechanism
3. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension
4. Effect on forearm arteries and veins of attenuation of the cardiac response to leg exercise
5. Nebivolol: A third generation β-blocker that augments vascular nitric oxide release. Endothelial β2-adrenergic receptor-mediated nitric oxide production
6. Recommendations on blood pressure measurement
7. Comparison and reproducibility of transthoracic bioimpedance and dual beam Doppler ultrasound
8. Animal pharmacology of nebivolol
9. Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function
10. Non invasive cardiac hemodynamics of nebivolol in men
11. Effects of nebivolol on haemodynamics, cardiac dimension and function, cardiovascular reflexes and bichemical measure of sympathetic activity in normal human subjects
12. Nitric oxide mediated venodilator effects of nebivolol
13. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation
14. Nebivolol reverses endothelial dysfunction in essential hypertension
15. Haemodynamic effects of nebivolol in men: Comparison of radionuclide angiocardiography with systolic time intervals
16. Influence of nebivolol on cardiovascular haemodynamics during postural changes and isometric exercise
17. Nebivolol in the treatment of cardiac failure: A double blind controlled clinical trial
18. Medium-term effects of beta-blockade on left ventricular mechanics: A double blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction
19. Long term (3-month) effect of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy
20. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease